Climate Change Data

ImmuCell Corporation

Climate Impact & Sustainability Data (2023, 2024-09-30)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Reducing antibiotic use in food-producing animals
  • Improving milk quality
  • Improving animal welfare

Environmental Achievements

  • Not disclosed

Social Achievements

  • Reduced reliance on antibiotics in livestock through preventative products (First Defense®) and a new treatment for mastitis (Re-Tain®) that does not require milk discard.
  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Exceed $35 million in annual total product sales within four years of Re-Tain® market launch.
Short-term Goals:
  • Increase and stabilize supply of First Defense®, regain lost business, and re-establish growth curve.
  • Achieve sales growth exceeding $17.5 million.

Environmental Challenges

  • Product contamination events impacting production output and sales.
  • Supply chain disruptions and inflationary pressures increasing costs.
  • High order backlog due to production shortfalls.
Mitigation Strategies
  • Implemented improvements at the source farm level, including more product and environmental testing, more training of farm staff, and better enforcement of protocols.
  • Improved production processes and controls to support large-scale production.
  • Investing in capacity expansion to meet growing demand.
  • Seeking insurance benefits to offset losses from contamination events.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Adverse weather conditions impacting colostrum supply and customer operations.
Transition Risks
  • Regulatory changes impacting antibiotic use in livestock.
  • Consumer preferences shifting away from animal products.
Opportunities
  • Development of energy-efficient products and processes.

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Goal 3 (Good Health and Well-being)
  • Goal 12 (Responsible Consumption and Production)
  • Goal 15 (Life on Land)

Initiatives contribute to these goals by reducing antibiotic use, improving animal health and welfare, and promoting sustainable agricultural practices.

Sustainable Products & Innovation

  • First Defense® (reducing antibiotic use)
  • Re-Tain® (alternative to traditional antibiotics)

Awards & Recognition

  • Not disclosed

Reporting Period: 2024-09-30

Environmental Metrics

Climate Goals & Targets

Medium-term Goals:
  • Exceed $35 million in annual product sales within four years of Re-Tain® launch.
Short-term Goals:
  • Increase and stabilize product supply.
  • Regain lost business and re-establish growth curve.
  • Achieve approximately $24 million in sales during 2024.

Environmental Challenges

  • Production contamination events impacting inventory and sales.
  • Supply chain disruptions and rising costs of goods sold.
  • Global economic uncertainty and inflation.
Mitigation Strategies
  • Implemented new production controls to remediate contamination issues.
  • Increased selling prices to offset rising costs.
  • Secured debt financing to offset lost sales and margin.
  • Exploring strategic partnerships to reduce product development expenses.

Supply Chain Management

Climate-Related Risks & Opportunities

Physical Risks
  • Altered rainfall, droughts, flooding, wildfires, rising sea levels, and heat index.
Transition Risks
  • Changes in regulations or consumer preferences related to livestock production.

Sustainable Products & Innovation

  • Re-Tain® (alternative to traditional antibiotics).